What is .decimal?
.decimal operates at the intersection of medical device manufacturing and patient-specific oncology care. The company specializes in the on-demand design and delivery of custom radiation therapy devices, which are essential for Proton, Electron, and Photon treatment modalities. With a proven track record of supporting over 150,000 cancer patients across 949 clinical sites, .decimal has successfully industrialized the production of personalized medical hardware. Having manufactured over 530,639 devices, the firm provides a unique value proposition through its contract manufacturing services and commitment to clinical safety standards, effectively bridging the gap between complex treatment planning and physical device implementation.
How much funding has .decimal raised?
.decimal has raised a total of $975K across 2 funding rounds:
Debt
$350K
Debt
$625K
Debt (2020): $350K with participation from PPP
Debt (2021): $625K led by PPP
Key Investors in .decimal
PPP
Public-Private Partnership
What's next for .decimal?
With the recent influx of capital, .decimal is well-positioned to further optimize its manufacturing throughput and expand its footprint within the radiation therapy market. The company's strategic focus will likely center on enhancing its digital design-to-delivery pipeline, ensuring that clinics can continue to receive high-precision, patient-specific devices with reduced lead times. As the demand for personalized cancer care grows, .decimal is poised to leverage its established infrastructure to integrate more deeply into the clinical workflows of major oncology centers, potentially exploring new material sciences or automated fabrication techniques to maintain its competitive edge in the medical technology landscape.
See full .decimal company page
